Cardiovascular Risk in T1D: LDL Focus and Beyond
Estimation of cardiovascular risk (CVR) in individuals living with type 1 diabetes (T1D) was a key topic presented by Sophie Borot, MD, from Besançon University Hospital, Besançon, France, at the 40th congress of the French Society of Endocrinology. Borot highlighted the complexities of this subject, outlining several factors that contribute to its challenges. A Heterogeneous […]
What's the Difference Between Vitamin D, D2 and D3?
Vitamin D is a nutrient that plays an important role in maintaining bone health, supporting your immune system and regulating mood. It exists primarily in two forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Understanding the differences between these two forms is essential for optimizing your health. Vitamin D3 is synthesized naturally in your skin […]
Woman Who Spent Days in Hospital with Painful Open Wound Waiting to Be Stitched Up Ends Up Losing Entire Leg
A 61-year-old woman from Canada had her right leg amputated following weeks of suffering and complications caused by delayed medical care after a knee replacement surgery. Roseanne Milburn’s health struggles began in October 2023 when she finally underwent a right knee replacement after waiting six years, CBC reported. In late November, a post-surgery infection required […]
FDA OKs Mesenchymal Stromal Cell Therapy for GVHD
The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute graft-vs-host disease (SR-aGVHD) in children 2 months of age or older. It’s the first MSC product approved by the FDA for any indication. According to a new release from the […]
New Autism Statistics Are Out, and They’re Shocking
Autism spectrum disorder (ASD) has surged in children in recent years, even among those who are just 4 years old. According to data from the Autism and Developmental Disabilities Monitoring (ADDM) Network, the overall prevalence of ASD in 2020 was 21.5 per 1,000 children aged 4.1 This marks a 26% increase from 2018, when the […]
Young Non-Smoker Died Of Terminal Lung Cancer After Symptoms Were Initially Dismissed As Anxiety
Do you think lung cancer only affects smokers? That’s what 36-year-old Liam Handley, and the doctors who examined this fit and healthy man from Derbyshire, U.K., believed until he was diagnosed with lung cancer. When Liam began experiencing chest pains, stress, and palpitations, doctors initially attributed it to anxiety, which he had struggled with for […]
Can AI Tool Guide CDK4/6 Inhibitor Use in Breast Cancer?
SAN ANTONIO — A machine learning model, which incorporates both clinical and genomic factors, helps predict which patients with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) metastatic breast cancer will benefit from adding a CDK4/6 inhibitor to frontline endocrine therapy, according to new research. There is a huge need to identify patients who […]
Microplastics Continue to Threaten Public Health
How to Use Progesterone Before you consider using progesterone, it is important to understand that it is not a magic bullet, and that you get the most benefit by implementing a Bioenergetic diet approach that allows you to effectively burn glucose as your primary fuel without backing up electrons in your mitochondria that reduces your […]
Louisiana Reports First Severe Human Case, California Declares Emergency Over Dairy Outbreak
As the H5N1 bird flu sweeps across the nation, health officials are sounding the alarm against the deadly virus. California, the nation’s most populous state, has declared a state of emergency after the virus struck hundreds of dairy herds, while Louisiana reports the first severe human case in a hospitalized patient. California Governor Gavin Newsom […]
FDA Approves Ensartinib for ALK+ Advanced NSCLC
The US Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of adults with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not previously received an ALK inhibitor. Approval for the new ALK-inhibitor was based on findings from the randomized, open-label, active-controlled eXalt3 trial, which found […]